Search Results - N. G. Kashevarova
- Showing 1 - 20 results of 34
- Go to Next Page
-
1
RISK FACTORS OF THE KNEE OSTEOARTHRITIS PROGRESSION by N. G. Kashevarova, L. I. Alekseeva
Published 2014-10-01The present review is devoted to the problem of progression of the knee osteoarthritis. It has been shown that the most important predictors of the disease progression are female gender, strong knee pain, synovitis,deformation of joints, high body mass index, previous traumas, high bone mineral dens...
Get full text
Article -
2
Efficacy of intra-articular of high molecular weight hyaluronic acid injections in in osteoarthritis of the knee and hip by L. I. Alekseeva, N. G. Kashevarova
Published 2021-09-01The presence of pain syndrome and an increase in functional insufficiency of the joints are the most frequent reasons for patients seeking medical help. Currently, given the growing prevalence of osteoarthritis, a more active multimodal approach to patient management is needed, taking into account t...
Get full text
Article -
3
Osteoarthritis: epidemiology, classification, risk factors, and progression, clinical presentation, diagnosis, and treatment by L. I. Alekseeva, E. A. Taskina, N. G. Kashevarova
Published 2019-05-01For the first time, the paper presents in detail the prevalence of osteoarthritis (OA) and considers the predictors of disease development and progression. The clinical classification of OA and its place in the ICD-10 are described. The clinical presentation of the disease is characterized in detail...
Get full text
Article -
4
FUNCTIONS OF THE mTOR SIGNALING PATHWAY IN NORMAL ARTICULAR CARTILAGE CHONDROCYTES AND IN OSTEOARTHRITIS by E. V. Chetina, N. G. Kashevarova, E. P. Sharapova
Published 2016-12-01Osteoarthritis (OA) is a chronic disease associated with pain, stiffness, limited mobility and joint inflammation, as well as articular cartilage destruction. Recent studies have shown the importance of chondrocyte differentiation (hypertrophy) as one of the mechanisms of cartilage degradation...
Get full text
Article -
5
The place of nonsteroidal anti-inflammatory drugs in the current osteoarthritis guidelines by E. A. Taskina, N. G. Kashevarova, L. I. Alekseeva
Published 2020-05-01The paper provides a review of the data available in the literature on the relationship of pain to the risk of OA progression. Network analyses and numerous studies, including those conducted at the V.A. Nasonova Research Institute of Rheumatology, have confirmed that pain syndrome is one of the sig...
Get full text
Article -
6
Symptomatic delayed-acting drugs (SYSADOA): new applications by A. M. Lila, E. A. Taskina, L. I. Alekseeva, N. G. Kashevarova
Published 2022-05-01The review systematizes modern data indicating effective pain control and a significant improvement in the functional activity of patients suffering from osteoarthritis (OA) using pharmaceutical substances of chondroitin sulfate (CS) and glucosamine (GA). The effect of a combination of CS and GA on...
Get full text
Article -
7
Multicenter Longitudinal Observational Study Pharmaceuticals Alflutop in Russia (message 2) by A. M. Lila, E. A. Taskina, L. I. Alekseeva, N. G. Kashevarova
Published 2023-08-01Osteoarthritis (OA) is one of the most important medical and social problems due to the steady increase in morbidity and disability. Prevention, management of risk factors, and early treatment of OA are critical.Objective of the ISKRA study was to evaluate the efficacy of Alflutop in patients with O...
Get full text
Article -
8
Osteoarthritis as an interdisciplinary problem: treatment algorithm for physicians and general practitioners by A. M. Lila, L. I. Alekseeva, E. A. Taskina, N. G. Kashevarova
Published 2021-10-01Modern therapy of osteoarthritis (OA) consists of four sequential stages and includes non-pharmacological, pharmacological and surgical methods of treatment, and also assumes the possibility of collaborative management of the patient by doctors of different specialties, which allows to optimize the...
Get full text
Article -
9
MULTIPLE BONE CYSTS CAUSED BY THE INTAKE OF LEFLUNOMIDE IN A FEMALE PATIENT WITH RHEUMATOID ARTHRITIS by L. I. Alekseeva, N. G. Kashevarova, E. A. Taskina, Ya. A. Sigidin
Published 2018-11-01The paper describes a clinical case of adverse reaction (AR) to leflunomide (LEF) in a female patient with rheumatoid arthritis (RA). In 2007 to 2017, the female patient with a reliable diagnosis of RA took LEF (Arava) at a dose of 20 mg/day, which showed a good clinical effect. However, the patient...
Get full text
Article -
10
Long-term multicenter observational study of the drug Alflutop in Russia: use in patients with knee osteoarthritis (report 4) by E. A. Taskina, L. I. Alekseeva, N. G. Kashevarova, A. M. Lila
Published 2024-08-01Objective: to investigate the efficacy of Alflutop therapy in patients with knee osteoarthritis (OA) with or without concomitant diseases. Material and methods. The large-scale, multicenter prospective, open-label, observational, non-interventional ISKRA study (Study: Prescribing the drug Alflutop,...
Get full text
Article -
11
Alflutop Russian longitudinal multicentre observational study: preliminary results (message 1) by A. M. Lila, L. I. Alekseeva, E. A. Taskina, N. G. Kashevarova
Published 2023-04-01Evaluation of the effect of new drugs should be carried out in randomized controlled trials (RCTs), and observational studies (OSs) are carried out to confirm and refine the results obtained in RCTs, for example, to study the effectiveness of drugs in large groups of patients who were not included i...
Get full text
Article -
12
Evaluation of the efficacy, tolerability, and safety of intra-articular hyaluronic acid in patients with knee osteoarthritis by S. G. Anikin, N. G. Kashevarova, T. A. Korotkova, E. P. Sharapova, L. I. Alekseeva
Published 2017-09-01Objective: to evaluate the efficacy, tolerability, and safety of intra-articular hyaluronic acid (hyalurom) in patients with knee osteoarthritis (OA).Patients and methods. A 6-month prospective trial enrolled 20 women aged 45–75 years (61±7 years) with primary knee OA of Kellgren–Lawrence grades II...
Get full text
Article -
13
Evaluation of the efficiency and safety of combined therapy with a symptomatic sustained-release drug and hyaluronic acid versus monotherapy with hyaluronic acid in patients with... by K. A. Berdyugin, I. V. Kadyntsev, O. V. Berdyugina, E. A. Taskina, N. G. Kashevarova
Published 2020-09-01Osteoarthritis (OA) is the most common joint disease. Searching for new treatment methods and regimens for OA is relevant.Objective: to evaluate the efficiency and safety of therapy with a symptomatic sustained-release drug (Alflutop) in combination with intra-articular hyaluronic acid (HA) injectio...
Get full text
Article -
14
Multimorbidity in osteoarthritis by E. A. Taskina, L. I. Alekseeva, N. G. Kashevarova, A. M. Lila, E. L. Nasonov
Published 2022-07-01This review is focused on the issue of terminology in patients with multiple coexisting diseases in modern clinical practice. We articulate that multimorbidity is one of the leading problems in the field of public healthcare and that the treatment of these patients demands an integral approach deriv...
Get full text
Article -
15
Comparison of continuous and intermittent treatment of patients with knee osteoarthritis with combined drug “Teraflex” by L I Alexeeva, N G Kashevarova, E P Sharapova, E M Saitseva, M. V. Severinova
Published 2008-06-01Objective. To assess efficacy, safety and aftereffect duration of continuous and intermittent treatment of patients with knee osteoarthritis with “Teraflex”. Material and methods. 100 outpatients (2 groups 50 pts in each) mainly women (99 pts) with knee osteoarthritis 0I-III stage according to Kellg...
Get full text
Article -
16
Assessment of efficacy and safety of “Chondroxid” gel in comparison with “Finalgel" in patients with knee osteoarthritis by L I Alexeeva, N G Kashevarova, E P Sharapova, E M Saitseva, M V Severinova
Published 2008-06-01Objective. To assess efficacy, safety and aftereffect duration of 6-week local therapy of “Chondroxid” gel in comparison with ‘‘Finalgel” in patients with knee osteoarthritis. Material and methods. 60 outpatients (2 groups 30 pts in each) mainly women (59 pts) with knee osteoarthritis (II-III stage...
Get full text
Article -
17
Efficacy of Chondroitin Sulfate in Patients with Knee and Hip Osteoarthritis by E. P. Sharapova, E. A. Taskina, N. G. Kashevarova, L. I. Alekseeva, A. M. Lila
Published 2021-08-01Currently chondroitin sulfate (CS) is the most studied drug from the group of «chondroprotectors». The article shows the role of CS in the treatment of osteoarthritis (OA): mechanism of action, clinical efficacy and safety in patients with OA with comorbidity. Evidence for the effectiveness and safe...
Get full text
Article -
18
The use of new aceclofenac dosage forms in patients with osteoarthrosis in real-life clinical practice by Lyudmila Ivanovna Alekseeva, E P Sharapova, N G Kashevarova, S G Anikin, T A Korotkova, E M Zaitseva
Published 2014-03-01A new convenient dosage form of aceclofenac (sashet bags) has recently been launched on the Russian market. The powder in a single sashet bag weighs 3 g, which corresponds to 100 mg of the active ingredient per tablet. A prospective study (including evaluation of the effectiveness and safety of the...
Get full text
Article -
19
Efficacy and safety of diacerein in patients with knee osteoarthritis by L. I. Alekseeva, N. G. Kashevarova, E. A. Taskina, E. P. Sharapova, S. G. Anikin, T. A. Korotkova, E. A. Strebkova
Published 2017-09-01Diacerein (D) belongs to a class of symptomatic slow-acting agents, has an original mechanism of action, and is widely used as a diseasemodifying antirheumatic drug to treat osteoarthritis (OA) in Russia and many countries of the world. The ability of the drug to affect the main symptoms and progres...
Get full text
Article -
20
Expression of genes related to glucose metabolism and joint destruction in the development of diabetes mellitus in patients with osteoarthritis by E. V. Chetina, E. P. Sharapova, N. G. Kashevarova, E. A. Taskina, G. A. Markova, L. I. Alekseeva, A. A. Lila
Published 2019-03-01Many patients with osteoarthritis (OA) tend to have comorbidities. This tendency is more frequently observed to increase with age. One of the comorbidities is type 2 diabetes mellitus (T2DM). Due to the higher prevalence of coexistence of these two conditions, it has been suggested that T2DM-associa...
Get full text
Article